← Back to Knowledge Center

Pharmaceutical Export to Bahrain from India | Global Entra Pharma

Pharmaceutical Export to Bahrain from India | Global Entra Pharma

Pharmaceutical Export to Bahrain from India

Pharmaceutical Export to Bahrain from India is an established international trade opportunity for pharmaceutical manufacturers, exporters, importers, distributors and healthcare companies seeking pharmaceutical products from India.

India has a strong pharmaceutical manufacturing industry and supplies finished pharmaceutical products to markets across the Middle East, Africa, Asia and other international regions. Bahrain is also an established pharmaceutical import market with India already supplying pharmaceutical products to the country.

According to World Bank WITS data, Bahrain imported approximately US$12.32 million of pharmaceutical products from India in 2024, while India's reported pharmaceutical exports to Bahrain were approximately US$9.39 million in 2025 under HS Chapter 30. Differences between importer and exporter figures can occur because of trade reporting and valuation methods.

Global Entra Pharma supports pharmaceutical sourcing from India for buyers in Bahrain, with a particular focus on suppositories, pessaries, vaginal ovules, pharmaceutical creams and pharmaceutical ointments.

Our pharmaceutical export services can include private-label manufacturing, contract manufacturing, bulk pharmaceutical supply, customized packaging and export documentation support, subject to product-specific regulatory requirements.

Pharmaceutical Exporter to Bahrain from India

Global Entra Pharma supports pharmaceutical companies, importers, distributors and healthcare businesses looking to source finished pharmaceutical products from Indian manufacturers.

Our pharmaceutical export capabilities can include:

  • Pharmaceutical suppositories

  • Pharmaceutical pessaries

  • Vaginal ovules

  • Pharmaceutical creams

  • Pharmaceutical ointments

  • Tablets and other dosage forms

  • Private-label pharmaceutical products

  • Contract manufacturing

  • Third-party manufacturing

  • Bulk pharmaceutical supply

  • Customized pharmaceutical packaging

  • Regulatory documentation

  • Export documentation

Each product is evaluated according to its formulation, strength, dosage form, intended use, manufacturing requirements and applicable Bahrain regulations.

Pharmaceutical Manufacturer in India for Bahrain

India is one of the world's major pharmaceutical manufacturing destinations, with manufacturing capabilities covering a wide range of therapeutic categories and dosage forms.

Pharmaceutical companies and importers in Bahrain can source from India for:

  • Finished pharmaceutical formulations

  • Specialized dosage forms

  • Dermatological products

  • Vaginal pharmaceutical products

  • Rectal suppositories

  • Pharmaceutical creams

  • Pharmaceutical ointments

  • Private-label products

  • Contract manufacturing

  • Custom packaging

  • Bulk pharmaceutical supply

Global Entra Pharma supports product sourcing and manufacturing coordination according to buyer specifications and applicable destination-market requirements.

Pharmaceutical Market in Bahrain

Bahrain's pharmaceutical market includes locally manufactured and imported medicines and pharmaceutical products.

India is already an established pharmaceutical supply partner for Bahrain. Bahrain reported approximately US$12.32 million in pharmaceutical imports from India during 2024, according to World Bank WITS data.

India's exporter-side data reported approximately US$9.39 million in pharmaceutical exports to Bahrain in 2025.

This existing trade relationship provides opportunities for Indian pharmaceutical manufacturers and exporters supplying products that meet Bahrain's regulatory, quality and commercial requirements.

Market opportunities can be assessed according to:

  • Pharmaceutical product demand

  • Therapeutic categories

  • Product registration

  • Import requirements

  • Local distribution

  • Pricing

  • Competition

  • Packaging

  • Buyer requirements

Pharmaceutical Products for Export to Bahrain

Global Entra Pharma can support enquiries for a range of finished pharmaceutical products, subject to manufacturing availability and regulatory assessment.

Our specialized dosage-form categories include:

  • Suppositories

  • Pessaries

  • Vaginal ovules

  • Pharmaceutical creams

  • Pharmaceutical ointments

Additional pharmaceutical dosage forms can also be evaluated according to the buyer's requirements.

Suppository Manufacturer in India for Bahrain

Global Entra Pharma supports enquiries for pharmaceutical suppositories manufactured in India for export to Bahrain.

Suppositories are specialized pharmaceutical dosage forms primarily intended for rectal administration. Depending on the active ingredient and formulation, they can be designed for selected local or systemic therapeutic applications.

Potential categories include:

  • Analgesic suppositories

  • Antipyretic suppositories

  • Anti-inflammatory suppositories

  • Haemorrhoidal suppositories

  • Anti-infective suppositories

  • Other specialized suppository formulations

The final formulation, strength, packaging and regulatory documentation are determined according to the specific product and destination-market requirements.

Pessary Manufacturer in India for Bahrain

Pessaries are pharmaceutical dosage forms designed primarily for vaginal administration.

Global Entra Pharma supports enquiries from pharmaceutical companies and distributors looking for pessary manufacturers in India for Bahrain.

Potential product categories include:

  • Antifungal pessaries

  • Antibacterial pessaries

  • Vaginal anti-infective products

  • Other specialized pharmaceutical pessaries

Before commercial supply, the product should be evaluated according to its formulation, classification, registration status and Bahrain regulatory requirements.

Vaginal Ovule Manufacturer in India for Bahrain

Vaginal ovules are specialized pharmaceutical dosage forms intended for vaginal administration.

Global Entra Pharma can support enquiries for vaginal ovule manufacturing in India for pharmaceutical companies, distributors and importers in Bahrain.

Potential formulations can be developed for selected:

  • Vaginal infections

  • Local gynecological applications

  • Vaginal pH-related applications

  • Other specialized pharmaceutical uses

Regulatory requirements depend on the active ingredients, formulation, strength, intended use and classification of the product.

Pharmaceutical Cream Manufacturer in India for Bahrain

Pharmaceutical creams are widely used topical dosage forms for dermatological and other local therapeutic applications.

Global Entra Pharma can support enquiries for pharmaceutical cream manufacturing, including:

  • Antifungal creams

  • Antibacterial creams

  • Anti-inflammatory creams

  • Dermatological creams

  • Combination creams

  • Moisturizing pharmaceutical creams

  • Other topical pharmaceutical formulations

Private-label pharmaceutical cream manufacturing can also be considered according to the buyer's specifications and applicable regulatory requirements.

Pharmaceutical Ointment Manufacturer in India for Bahrain

Pharmaceutical ointments are semi-solid formulations primarily designed for topical application.

Potential pharmaceutical ointment categories include:

  • Antibacterial ointments

  • Antifungal ointments

  • Anti-inflammatory ointments

  • Wound-care ointments

  • Protective ointments

  • Dermatological ointments

  • Other topical pharmaceutical formulations

Global Entra Pharma can coordinate manufacturing and export requirements according to the buyer's product specifications.

Five Specialized Pharmaceutical Dosage Forms

Global Entra Pharma focuses on five specialized pharmaceutical dosage forms for international markets:

1. Suppositories

Specialized rectal dosage forms for selected pharmaceutical applications.

2. Pessaries

Vaginal pharmaceutical dosage forms designed for localized applications.

3. Vaginal Ovules

Specialized vaginal preparations manufactured according to product specifications.

4. Pharmaceutical Creams

Topical semi-solid pharmaceutical formulations for dermatological and other local applications.

5. Pharmaceutical Ointments

Semi-solid topical pharmaceutical formulations for various therapeutic applications.

These specialized dosage forms can be evaluated for export to Bahrain according to product-specific registration and import requirements.

Pharmaceutical Registration in Bahrain

Pharmaceutical registration is an important step before a medicine can be marketed in Bahrain.

The National Health Regulatory Authority (NHRA) Bahrain is responsible for regulating medicines and pharmaceutical products in the country.

The current NHRA Medicines Licensing Guideline includes requirements relating to product information, packaging artwork, GMP documentation, CPP documentation, certificates of analysis and manufacturing-site information.

The applicable registration pathway can depend on:

  • Active pharmaceutical ingredient

  • Dosage form

  • Strength

  • Product classification

  • Manufacturer

  • Country of origin

  • Marketing authorization holder

  • Intended use

  • Local representative

  • Registration pathway

The current NHRA requirements should be confirmed for every pharmaceutical product before commercial registration or importation.

Drug Registration Requirements in Bahrain

A pharmaceutical registration submission may require administrative, technical, quality and manufacturing information.

Depending on the product and applicable registration pathway, documentation may include:

  • Product registration application

  • Manufacturer information

  • Manufacturing licence

  • GMP certificate

  • Certificate of Pharmaceutical Product

  • Free Sale Certificate where applicable

  • Product composition

  • Manufacturing process

  • Finished-product specifications

  • Analytical information

  • Certificate of Analysis

  • Stability data

  • Packaging information

  • Product labeling

  • Package insert

  • Product samples where required

  • Other supporting regulatory documents

The final documentation checklist should be confirmed with NHRA or the authorized local applicant before submission.

Pharmaceutical Dossier for Bahrain

A complete pharmaceutical dossier organizes the technical information required for regulatory evaluation.

Depending on the applicable requirements, the dossier may contain:

  • Administrative information

  • Product information

  • Active pharmaceutical ingredient information

  • Pharmaceutical development

  • Manufacturing information

  • Quality-control information

  • Finished-product specifications

  • Analytical methods

  • Stability information

  • Packaging information

  • Labeling

  • Product literature

Where a CTD or equivalent structured dossier is applicable, the dossier should be prepared according to the current Bahrain regulatory requirements.

GMP Requirements for Pharmaceutical Export to Bahrain

Good Manufacturing Practice documentation is an important part of pharmaceutical registration.

The current NHRA Medicines Licensing Guideline identifies GMP documentation for finished-product manufacturers and API manufacturers. It also addresses relevant manufacturing and batch-release sites.

Supporting documentation can include:

  • Finished-product manufacturer GMP certificate

  • API manufacturer GMP certificate

  • Manufacturing licence

  • Manufacturing-site information

  • Quality-management documentation

  • Product specifications

  • Quality-control documentation

  • Batch documentation

A WHO-GMP certificate may support an international regulatory submission, but exporters should verify the exact GMP documentation accepted for the specific product and registration route.

Certificate of Pharmaceutical Product for Bahrain

A Certificate of Pharmaceutical Product (CPP) is an important document for pharmaceutical registration.

The current NHRA guideline specifies a CPP in the WHO format, subject to the applicable authentication, legalization or electronic-verification requirements.

The CPP should correspond to the product, manufacturer and regulatory information submitted in the pharmaceutical dossier.

Free Sale Certificate for Bahrain

A Free Sale Certificate (FSC) or equivalent marketability document may be requested depending on the applicable registration pathway.

An FSC can provide evidence concerning the legal marketing status of a pharmaceutical product in its country of origin.

The importer and exporter should confirm the current FSC requirements for the specific product before preparing the registration dossier.

Local Pharmaceutical Importer in Bahrain

A qualified local pharmaceutical company, applicant or authorized representative can be important for pharmaceutical registration and market access in Bahrain.

The local partner may assist with:

  • Product registration

  • Regulatory communication

  • Import procedures

  • Customs clearance

  • Warehousing

  • Distribution

  • Local market activities

  • Regulatory follow-up

The responsibilities of the Indian manufacturer, exporter and Bahraini applicant should be clearly established before beginning the registration process.

Pharmaceutical Import Requirements in Bahrain

Pharmaceutical imports into Bahrain are subject to applicable health-product, import and customs requirements.

Depending on the product, documentation can include:

  • Product registration documentation

  • Import authorization

  • Commercial invoice

  • Packing list

  • Certificate of Origin

  • Certificate of Analysis

  • GMP certificates

  • CPP

  • Product labeling

  • Package insert

  • Shipping documents

  • Other documents requested by the relevant authorities

Additional requirements may apply to controlled or specially regulated medicines.

Pharmaceutical Stability Data for Bahrain

Stability data supports the proposed shelf life and storage conditions of pharmaceutical products.

Depending on the product and regulatory pathway, stability documentation may include:

  • Accelerated stability studies

  • Long-term stability studies

  • Stability protocol

  • Stability results

  • Proposed shelf life

  • Storage conditions

  • Packaging configuration

Stability data should correspond to the final formulation and packaging configuration.

Certificate of Analysis for Pharmaceutical Export

A Certificate of Analysis (CoA) provides batch-specific quality information for a pharmaceutical product.

It can include:

  • Product name

  • Batch number

  • Manufacturing date

  • Expiry date

  • Identification

  • Assay

  • Physical characteristics

  • Microbiological parameters

  • Other product-specific tests

  • Specification limits

  • Test results

The current NHRA guideline identifies certificates of analysis for drug substances and finished products among the relevant documentation.

Pharmaceutical Manufacturing Licence in India

Pharmaceutical products supplied from India should be manufactured at appropriately authorized pharmaceutical facilities.

Supporting documentation may include:

  • Manufacturing licence

  • GMP certificate

  • Manufacturing-site information

  • Product authorization

  • Quality certificates

  • Product specifications

  • Other regulatory documents

The specific documents required for Bahrain registration depend on the product and applicable NHRA requirements.

Pharmaceutical Export Documents from India to Bahrain

A pharmaceutical shipment from India can require commercial, regulatory and shipping documentation.

Common documents may include:

  • Commercial Invoice

  • Packing List

  • Certificate of Origin

  • Bill of Lading or Air Waybill

  • Certificate of Analysis

  • GMP certificate

  • Manufacturing documents

  • CPP

  • Free Sale Certificate where applicable

  • Product registration documents

  • Import authorization

  • Export documentation

  • Other buyer- or authority-required documents

The final document package should be confirmed for the specific product and shipment.

Pharmaceutical Packaging for Bahrain

Pharmaceutical packaging should comply with the approved product information and applicable Bahrain requirements.

The current NHRA guideline includes packaging artwork and both Arabic and English product leaflets among the medicine licensing documentation.

Packaging formats may include:

  • Blister packs

  • Strip packs

  • Tubes

  • Containers

  • Pharmaceutical cartons

  • Labels

  • Arabic and English package leaflets

  • Shipping cartons

For private-label products, packaging artwork can be developed according to the buyer's brand and approved regulatory information.

Private Label Pharmaceutical Manufacturing for Bahrain

Private-label pharmaceutical manufacturing allows a pharmaceutical company or distributor in Bahrain to market a pharmaceutical product under its own brand, subject to applicable registration requirements.

Global Entra Pharma can support private-label projects involving:

  • Product selection

  • Pharmaceutical manufacturing

  • Product specifications

  • Brand development

  • Packaging

  • Carton artwork

  • Labeling

  • Regulatory documentation

  • Export documentation

The finished product must meet applicable regulatory requirements before commercial distribution.

Contract Pharmaceutical Manufacturing for Bahrain

Contract manufacturing allows pharmaceutical companies and distributors in Bahrain to source finished pharmaceutical products from Indian manufacturing facilities.

Potential services include:

  • Pharmaceutical manufacturing

  • Product development

  • Private-label production

  • Packaging

  • Quality control

  • Batch documentation

  • Regulatory documentation

  • Export support

Responsibilities between the Indian manufacturer, exporter and Bahraini applicant should be clearly defined before production and registration.

Bulk Pharmaceutical Supply to Bahrain

Global Entra Pharma can support enquiries for bulk pharmaceutical supply to Bahrain from India.

Bulk orders can be evaluated according to:

  • Product

  • Strength

  • Dosage form

  • Quantity

  • Packaging

  • MOQ

  • Registration status

  • Delivery destination

  • Commercial terms

Large-volume pharmaceutical supply should be planned after confirming the applicable registration and import requirements.

Quality Control for Pharmaceutical Export

Quality control is a fundamental part of pharmaceutical manufacturing and international supply.

Depending on the product, quality-control activities may include:

  • Raw-material testing

  • In-process testing

  • Finished-product testing

  • Microbiological testing

  • Analytical testing

  • Stability testing

  • Batch documentation

  • Certificate of Analysis

Testing requirements depend on the product specification and applicable standards.

Why Source Pharmaceutical Products from India?

India is an established global pharmaceutical manufacturing and export hub.

International buyers can benefit from access to:

  • Broad pharmaceutical manufacturing capabilities

  • Specialized dosage forms

  • Competitive manufacturing

  • Private-label production

  • Contract manufacturing

  • Bulk pharmaceutical supply

  • Flexible packaging

  • Regulatory documentation

  • International export experience

For pharmaceutical companies in Bahrain, product selection should consider quality, regulatory compliance, market demand, pricing and distribution requirements.

Global Entra Pharma – Pharmaceutical Supplier to Bahrain

Global Entra Pharma supports pharmaceutical sourcing enquiries from pharmaceutical companies, importers, distributors and healthcare businesses in Bahrain.

Our specialized pharmaceutical categories include:

  • Suppositories

  • Pessaries

  • Vaginal ovules

  • Pharmaceutical creams

  • Pharmaceutical ointments

Other finished pharmaceutical products can also be evaluated according to buyer requirements and manufacturing capabilities.

Pharmaceutical Export Process from India to Bahrain

The pharmaceutical export process can generally involve the following stages:

Step 1 – Product Enquiry

The Bahraini buyer provides the product name, strength, dosage form and required quantity.

Step 2 – Product Evaluation

The product is evaluated for manufacturing availability and regulatory requirements.

Step 3 – Commercial Quotation

Pricing, MOQ, packaging and delivery terms are discussed.

Step 4 – Regulatory Assessment

The applicable Bahrain registration and import requirements are identified.

Step 5 – Dossier Preparation

The required administrative and technical documentation is prepared.

Step 6 – Product Registration

Where required, the local applicant proceeds with pharmaceutical registration.

Step 7 – Regulatory Approval

The product proceeds through the applicable NHRA review.

Step 8 – Import Authorization

The importer completes the applicable import process.

Step 9 – Manufacturing and Quality Control

The product is manufactured and tested according to the agreed specifications.

Step 10 – Export Shipment

The required export and shipping documents are prepared and the pharmaceutical shipment is dispatched to Bahrain.

How to Source Pharmaceutical Products from India for Bahrain

Bahraini pharmaceutical companies and importers can provide the following information when requesting a quotation:

  • Product name

  • Generic name

  • Strength

  • Dosage form

  • Required quantity

  • Packaging requirement

  • Private-label requirement

  • Brand name

  • Registration status

  • Required documentation

  • Delivery destination

Providing complete information helps the exporter evaluate the commercial and regulatory requirements efficiently.

Frequently Asked Questions

Is pharmaceutical export from India to Bahrain possible?

Yes. India is an established pharmaceutical supplier to Bahrain. Bahrain reported approximately US$12.32 million in pharmaceutical imports from India in 2024, while India reported approximately US$9.39 million in pharmaceutical exports to Bahrain in 2025.

Can suppositories be exported from India to Bahrain?

Yes, suppositories can be evaluated for export subject to applicable product registration, import authorization and NHRA requirements.

Can pessaries be exported to Bahrain?

Yes. Pharmaceutical pessaries can be evaluated for registration and export according to their formulation, classification and intended use.

Can vaginal ovules be exported to Bahrain?

Vaginal ovules can be considered for pharmaceutical export after evaluating their formulation, classification and applicable registration requirements.

Can pharmaceutical creams be exported to Bahrain?

Yes. Pharmaceutical creams can be supplied subject to applicable registration, labeling and import requirements.

Can pharmaceutical ointments be exported to Bahrain?

Yes. Pharmaceutical ointments can be evaluated for export according to the applicable regulatory requirements.

Is GMP documentation required for pharmaceutical registration in Bahrain?

Yes. The current NHRA medicine licensing guideline identifies GMP documentation for relevant finished-product and API manufacturers.

Is a CPP required for pharmaceutical registration in Bahrain?

The current NHRA Medicines Licensing Guideline specifies a WHO-format CPP as part of the medicine licensing documentation.

Are Arabic and English leaflets required?

The current NHRA guideline identifies Arabic and English product leaflets among the medicine licensing documentation.

Can Global Entra Pharma manufacture private-label pharmaceutical products for Bahrain?

Yes. Private-label pharmaceutical manufacturing can be considered according to product specifications, manufacturing capabilities and applicable Bahrain regulatory requirements.

Can pharmaceutical products be purchased in bulk from India?

Yes. Bulk pharmaceutical supply can be evaluated according to product, quantity, packaging, MOQ, registration status and commercial requirements.

How can a pharmaceutical company in Bahrain request a quotation?

The buyer can provide the product name, strength, dosage form, quantity, packaging requirements and delivery destination for commercial and regulatory evaluation.

Request Pharmaceutical Export to Bahrain from India

Looking for a pharmaceutical manufacturer or pharmaceutical exporter from India to Bahrain?

Global Entra Pharma can support enquiries for:

  • Pharmaceutical suppositories

  • Pharmaceutical pessaries

  • Vaginal ovules

  • Pharmaceutical creams

  • Pharmaceutical ointments

  • Private-label pharmaceutical products

  • Contract manufacturing

  • Bulk pharmaceutical supply

Send your product name, strength, dosage form, required quantity, packaging requirements and destination details for commercial and regulatory evaluation.


Related Articles

Top Pharmaceutical Export Company in India | Global Entra Pharma

Read More
Suppository Manufacturer in India | WHO-GMP Exporter | Global Entra Pharma

Global Entra Pharma is a leading suppository manufacturer in India offering WHO-GMP manufacturing, private labeling, contract manufacturing, and export-ready pharmaceutical suppositories for global markets.

Read More
Vaginal Ovules Manufacturer in India | WHO-GMP Exporter | Global Entra Pharma

Discover why India is a preferred destination for vaginal ovule manufacturing. Learn about WHO-GMP production, contract manufacturing, quality standards, export capabilities, and private labeling services offered by Global Entra Pharma.

Read More